Regulatory Submissions Lodged for Felix

Memphasys Limited (ASX: MEM) (“Memphasys” or “the Company”) is pleased to confirm it has formally lodged regulatory submissions for the Felix™ System with both the Australian Therapeutic Goods Administration (TGA) and India’s Central Drugs Standard Control Organisation (CDSCO). These submissions follow the Company’s successful CE Mark approval for Felix™1 and were undertaken in line with guidance